trial

Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease

NCTId NCT04946916
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 120 (estimated)
Sponsored by Hôpital le Vinatier
Primary completion 2027-03-22
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2021-10-22
Primary completion
2027-03-22
Eligibility
ALL · 45 Years · 80 Years

Interventions & indications

Drugs
blood sample taken

Sponsors

Hôpital le VinatierLead Sponsor

Investigators

1
Jean-Michel DOREY, MD, PHDPrincipal Investigator

Sites

2 total
Bron, FranceBron, France

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2027-03-22
Status
RECRUITING
relationships
The graph out of here
drug
blood sample taken
drug
lead_sponsor
Hôpital le Vinatier
company
indication
Bipolar Disorder
indication
Dementia
indication
Alzheimer Disease
indication
investigator
Jean-Michel DOREY, MD, PHD
person